Geron scientists highlight importance of telomerase inhibitor, GRN163L at AACR 2010

[News]

Geron Corporation today announced five presentations by Geron scientists and collaborators on the company's telomerase inhibitor, imetelstat sodium, including the drug's activity against cancer stem cells, at the 101st American Association for Cancer Research annual meeting held in Washington D.C.

More... (http://www.news-medical.net/news/20100423/Geron-scientists-highlight-importance-of-telomerase-inhibitor-GRN163L-at-AACR-2010.aspx)